Skip to main content
main content, press tab to continue
Article

Asset Manager Market Update – Great Britain & North America - 2024 H1.

April 22, 2024

A market update of the asset management industry focusing on D&O and E&O insurance.
Financial, Executive and Professional Risks (FINEX)
N/A

In this H1 2024 Asset Management Market Update, we are pleased to provide our thoughts on the current state of the insurance market for asset managers and the funds they manage, and some thoughts on what to expect throughout 2024.

During recent months, the environment for procuring Professional Indemnity (PI)/Errors and Omissions (E&O) and Directors’ and Officers’ (D&O) Liability insurance – collectively known as investment management insurance (IMI) – has been favourable for asset managers. The combination of aggressive insurer growth targets and new entrants in the global insurance market have increased competition and capacity available in all major markets. IMI renewals through 2023 achieved premium reductions in most cases and we expect this pattern to continue through 2024.

Effective risk management and corporate governance remain high on the agenda of firms and regulators worldwide, with continued focus on ESG factors as well as operational resilience, especially in the context of cyber security. The evolving regulatory framework across financial services requires a dynamic approach to risk management, and at WTW we remain fully engaged in supporting our clients manage the latest risk trends and developments impacting asset managers. We are committed to achieving the best possible insurance outcomes for our clients as a key part of their risk management strategies.

Should you have any questions or wish to discuss any of these issues in greater detail, please do contact me or a member of your WTW team.

Download
Title File Type File Size
H1 2024 - asset manager market update – gb & na PDF 1.7 MB
Contacts

GB Head of FINEX Financial Institutions

Global Head of FINEX Financial Institutions
email Email

Asset Management Industry Leader, GB
email Email

Contact us